About Us

Elevion Pharma: Guiding your medicines from development to market with expert regulatory support.

About Elevion Pharma

Elevion Pharma is a UK‑based global leader in Human Medicines Regulatory Affairs. We partner with companies to accelerate approval strengthen compliance, and maximise commercial success through tailored, high‑impact regulatory strategies.

Our approach goes beyond traditional regulatory support. We deliver agile, innovative, and commercially aligned solutions that anticipate regulatory expectations and support your product’s strategic positioning. From early development to post‑approval lifecycle management, we ensure your submissions are robust, your licences are secured efficiently, and your products meet the highest standards of quality, efficacy, and safety.

Serving clients across the UK, EU, and MENA regions, we provide comprehensive regulatory, PV and compliance services that help you navigate complex global requirements and unlock new business opportunities.

Choose Elevion Pharma for forward‑thinking regulatory expertise that drives approvals, supports growth, and elevates your competitive advantage in the pharmaceutical industry.

150+

15

Trusted worldwide

Proven results

Book a Free Consultation

Team Expertise

Our team brings together over three decades of combined experience across regulatory authorities, top global pharmaceutical companies, consumer healthcare organisations, pharma and digital transformation consultancies in the EU, UK and MENA regions. This diverse background enables us to support a wide spectrum of regulatory and strategic projects with precision, depth, and real‑world insight.

Regulatory Affairs Excellence Across UK, EU & Global Markets

The team has extensive hands‑on experience with:

  • · MHRA,EMA and MENA

  • · Marketing Authorisation Applications (MAAs)

  • · Clinical Trial Applications (CTAs) and [DT1] modifications.

  • · Paediatric Investigation Plans (PIPs)Scientific Advice and Pre-submission meetings

  • · Lifecycle management - variations, renewals, and post‑approval activities

  • · Orphan product and rare disease regulatory support – ODDs, EAMS and Compassionate use.

  • · Product Information development (SmPC, PIL, CCDS, labelling, mock-ups)

  • · Pre-vetting, aRMMs, promotional and non-promotional materials review.

  • · The Windsor Framework and post-Brexit regulatory landscape

  • · Innovative and generic products

This includes regulatory leadership for portfolios in Virology, Oncology, ATMPs, Rare Diseases, Anti-Infectives, Biologics, Sterile and Injectables, Endocrinology, Topical formulations, Consumer Healthcare, and Medical Devices, ensuring alignment with global development plans and regional requirements.

Experience Across Leading Organisations

Team members have contributed to regulatory strategy and execution within:

  • · Global pharma leaders: Gilead, AstraZeneca, Pfizer, MSD, Alexion, Teva, Crescent Pharma

  • · Consumer healthcare giants: GSK Consumer Healthcare

  • · Regulatory authorities: MHRA

  • · Digital transformation consultancies: Infosys

This breadth ensures familiarity with both authority-side expectations and industry-side delivery, enabling well‑rounded, practical guidance.

Digital Transformation & Regulatory Technology

The team also brings strong digital capability, including:

  • · Veeva Vault RIM (advanced lifecycle workflows)

  • · PROTON, CRM Dynamics

  • · SQL, BI tools (Power BI, Tableau)

  • · Process modelling and SDLC

  • · Digital Twin architecture development

  • · AI/GenAI applications for workflow optimisation

This combination of regulatory and digital expertise allows us to support modernisation initiatives, data-driven decision-making, and operational efficiency improvements.

Cross‑Functional & Strategic Leadership

Team members have represented Regulatory Affairs in:

  • · Global project teams

  • · Cross-functional development programmes

  • · Strategic initiatives involving CMC, Clinical, Medical, Safety, Supply Chain, and Commercial teams

  • · Diversity & inclusion programmes and organisational engagement groups

This ensures strong communication, stakeholder management, and the ability to navigate complex organisational environments.

What This Means for You

With this combined expertise, our team can confidently support:

  • · Early development regulatory strategy

  • · Clinical trial submissions and maintenance

  • · Pre-MAA supply

  • · EU/UK, MENA marketing authorisation pathways

  • · Post‑approval lifecycle management

  • · Labelling and compliance reviews

  • · Regulatory intelligence and risk mitigation

  • · Digital transformation of regulatory processes

  • · Workflow optimisation and documentation excellence

Whether your query is scientific, strategic, operational, or digital, our team has the experience to provide informed, practical, and high‑quality support.

Elevion Pharma’s guidance made our regulatory process smooth and stress-free.

Dr. Lee

A smiling professional woman in a lab coat reviewing documents in a bright office.
A smiling professional woman in a lab coat reviewing documents in a bright office.
A close-up of hands shaking over a contract, symbolizing partnership and trust.
A close-up of hands shaking over a contract, symbolizing partnership and trust.

★★★★★

Contact Us

A welcoming office reception area with a friendly team ready to assist clients.
A welcoming office reception area with a friendly team ready to assist clients.

Reach out to Elevion Pharma for expert regulatory support tailored to your needs.